期刊文献+

Challenges and counter challenges in HIV/AIDS

原文传递
导出
摘要 Since the beginning of the HIV/AIDS pandemic,there has been significant progress in combating the virus.In addition to identifying HIV,1 scientists have developed an array of antiretroviral drugs and successfully converted the once deadly disease into a treatable and chronic condition.2 Nevertheless,this battle is far from over and HIV still outsmarts humans in multiple ways and poses tremendous challenges.Within this context,the Chinese Medical Journal has timely published this special issue on HIV/AIDS,highlighting the ongoing challenges posed by HIV and potential solutions to these problems.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第23期3379-3380,共2页 中华医学杂志(英文版)
  • 相关文献

参考文献5

二级参考文献16

  • 1García de Viedma D,del Sol Díaz Infantes M,Lasala F,Chaves F,Alcalá L,Bouza E.New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis.J Clin Microbiol 2002; 40:988-995.
  • 2Lindstr(o)m A,Albert J.A simple and sensitive "in-house"method for determining genotypic drug resistance in HIV-1.J Virol Methods 2003; 107:45-51.
  • 3Eshleman SH,Crutcher G,Petrauskene O,Kunstman K,Cunningham SP,Trevino C,et al.Sensitivity and specificity of the viroseq human immunodeficiency virus type 1 (HIV-1)genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.J Clin Microbiol 2005; 43:813-817.
  • 4Erali M,Page S,Reimer LG,Hillyard DR.Human immunodeficiency virus type 1 drug resistance testing:a comparison of three sequence-based methods.J Clin Microbiol 2001; 39:2157-2165.
  • 5Bergroth T,S(o)nnerborg A,Yun Z.Discrimination of lamivudine resistant minor HIV-1 variants by selective real-time PCR.J Virol Methods 2005; 127:100-107.
  • 6Johnson JA,Li JF,Wei X,Lipscomb J,Bennett D,Brant A,et al.Simple PCR assays improve the sensitivity of HIV-1subtype B drug resistance testing and allow linking of resistance mutations.PLoS One 2007; 25:e638.
  • 7Paredes R,Marconi VC,Campbell TB,Kuritzkes DR.Systematic evaluation of allele-specific real-time PCR for the detection of minor HIV-1 variants with pol and env resistance mutations.J Virol Methods 2007; 146:136-146.
  • 8Church JD,Towler WI,Hoover DR,Hudelson SE,Kumwenda N,Taha TE,et al.Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants.AIDS Res Hum Retroviruses 2008; 24:595-605.
  • 9Johnson JA,Li JF,Wei X,Lipscomb J,Irlbeck D,Craig C,et al.Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy.PLoS Med 2008; 5:e158.
  • 10Shafer RW,Schapiro JM.HIV-1 drug resistance mutations:an updated framework for the second decade of HAART.AIDS Rev 2008; 10:67-84.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部